G1 Therapeutics Pre-Tax Profit Margin 2016-2024 | GTHX
G1 Therapeutics pre-tax profit margin from 2016 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2024-06-30 |
$0.06B |
$-0.04B |
-72.41% |
2024-03-31 |
$0.08B |
$-0.03B |
-32.53% |
2023-12-31 |
$0.08B |
$-0.05B |
-54.88% |
2023-09-30 |
$0.08B |
$-0.07B |
-88.31% |
2023-06-30 |
$0.09B |
$-0.08B |
-84.27% |
2023-03-31 |
$0.06B |
$-0.12B |
-213.79% |
2022-12-31 |
$0.05B |
$-0.15B |
-278.85% |
2022-09-30 |
$0.05B |
$-0.15B |
-316.67% |
2022-06-30 |
$0.03B |
$-0.17B |
-586.21% |
2022-03-31 |
$0.03B |
$-0.17B |
-680.00% |
2021-12-31 |
$0.03B |
$-0.15B |
-459.38% |
2021-09-30 |
$0.04B |
$-0.13B |
-306.98% |
2021-06-30 |
$0.07B |
$-0.10B |
-155.38% |
2021-03-31 |
$0.06B |
$-0.09B |
-155.00% |